Aker BioMarine posts 12% revenue growth in Q2

Aker BioMarine reported revenue of USD 55.3 million for the second quarter, up 12% year-over-year, with adjusted EBITDA rising 41% to USD 13.6 million.

The Human Health Ingredients segment drove performance with USD 29.2 million in revenue and 28% growth in adjusted EBITDA to USD 13.9 million, benefiting from strong demand and improved pricing.

Consumer Health Products generated USD 27.1 million in revenue, up 9% year-over-year, while maintaining stable margins through cost control.